CSRxP Statement on Secretary Azar’s Testimony in Front of Senate HELP Committee

“When the manufacturer-set price of a drug starts out high, the price of that drug when it reaches patients will inevitably end up high.  No amount […]

Read more

46 Signatories Applaud Grassley & Feinstein for CREATES Act Markup

46 organizations today applauded Chairman Chuck Grassley and Ranking Member Dianne Feinstein for scheduling a markup of the bipartisan, bicameral Creating and Restoring Equal Access to […]

Read more

CSRxP Statement on HHS OIG Part D Spending Report

Today, the Office of the Inspector General at the Department of Health and Human Services (OIG) released a report entitled, “Increases in Reimbursement for Brand-Name Drugs […]

Read more

CSRxP Applauds FDA’s Focus on REMS Abuses

The Campaign for Sustainable Rx Pricing released the following statement attributable to CSRxP spokesman Will Holley: “Today’s FDA guidance is a step in the right direction […]

Read more